Status:
COMPLETED
Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
GlaxoSmithKline
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The primary objective of the study is to identify demographic and non-spirometric clinical features predictive of the asthma-COPD overlap population. The study aims to explore and identify characteris...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subject must be 18 years of age or older.
- Subject has been diagnosed as having asthma and/or COPD.
- Informed consent is required for independent sites initiating this protocol
Exclusion
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 28 2015
Estimated Enrollment :
1215 Patients enrolled
Trial Details
Trial ID
NCT02302417
Start Date
January 1 2015
End Date
May 28 2015
Last Update
September 11 2017
Active Locations (42)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Newport Beach, California, United States, 92663
2
GSK Investigational Site
Upland, California, United States, 91786
3
GSK Investigational Site
Sunset, Louisiana, United States, 70584
4
GSK Investigational Site
Charlotte, North Carolina, United States, 28207